Protein Activation in Drug Discovery - Part-II

Qi       Chen; Junliang      Hao

doi:10.2174/156802661926191114102544

« Previous Next »

[1] 
Reinecke, B.A.; Wang, H.; Zhang, Y. Recent advances in the drug discovery and development of dualsteric/bitopic activators of G protein-coupled receptors. Curr. Top. Med. Chem.,  2019, 19(26), 2378-2392.
[2] 
Sniecikowska, J.; Newman-Trancredi, A.; Kolaczkowski, M. From receptor selectivity to functional selectivity: the rise of biased agonism in 5-HT1A receptor drug discovery. Curr. Top. Med. Chem.,  2019, 19(26), 2393-2420.
[3] 
Hao, J.; Chen, Q. Insights into the structural aspects of the mGlu receptor orthosteric binding site. Curr. Top. Med. Chem.,  2019, 19(26), 2421-2446.

Download Options

Rights & Permissions Print Cite

Current Topics in Medicinal Chemistry

Title:Protein Activation in Drug Discovery - Part-II

Volume: 19 Issue: 26

Author(s): Qi Chen and Junliang Hao

Affiliation:

Export Options

Export File:

RIS (for EndNote, Reference Manager, ProCite)

BibTeX

Text

Content:

Citation Only

Citation and Abstract

About this article

Cite this article as:

Chen Qi and Hao Junliang, Protein Activation in Drug Discovery - Part-II, Current Topics in Medicinal Chemistry 2019; 19 (26) . https://dx.doi.org/10.2174/156802661926191114102544

DOI https://dx.doi.org/10.2174/156802661926191114102544	Print ISSN 1568-0266
Publisher Name Bentham Science Publisher	Online ISSN 1873-4294

About this journal

Call for Papers in Thematic Issues

Submission closes on : 30 September, 2024

Medicinal Chemistry Advancement in Life-Threatening Diseases

The current issue will highlight concise reports that specify ground-breaking insights, including the novel discovery of drug targets and their action mechanism or drugs of novel classes. These are projected to encourage medicinal chemistry future efforts to address the most challenging medical needs. The current issue highlights further efforts to ...read more

Guest Editor(s): Ajmal Khan